Photo of Emma Kerr

Emma Kerr


  • Room 03.007 - CCRCB

    United Kingdom

Accepting PhD Students


Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests


Cancer cells frequently hijack the metabolic processes hardwired in normal cells to support their enhanced growth, proliferation and spread. Importantly, changes in tumour cell metabolism can present novel vulnerabilities, that when targeted pharmacologically can limit tumour growth; and also alter the sensitivity of these tumour cells to standard-of-care chemotherapies and targeted therapies. Thus, defining the impact of metabolic reprogramming on dictating therapeutic susceptibilities and driving resistance mechanisms is imperative to improving treatment response for cancer patients.

Our aim is to integrate state-of-the-art cancer models, metabolic analyses and multi-omics platforms to comprehensively map metabolic reprogramming, uncover induced vulnerabilities, mechanisms of drug resistance and novel therapeutic opportunities in defined cancer subtypes (KRASmutantTP53mutant/nullAPCmutant/null), allowing us to better aid in patient stratification, and suggesting novel therapeutic combinations to improve patient outcome.


Dr Kerr is a CRUK Career Development Fellowship holder


Dive into the research topics where Emma Kerr is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 16 Similar Profiles


Recent external collaboration on country level. Dive into details by clicking on the dots.
If you made any changes in Pure these will be visible here soon.